Court Rules
All enforcement actions
Enforcement ActionCritical Risk

Oregon AG Sues Insulin Makers, PBMs for $900M Price Fixing

Novo Nordisk, Sanofi, Eli Lilly, Express Scripts, CVS Caremark, OptumJanuary 7, 2026Oregon Attorney General

Penalty Amount

$900,000,000

Summary

Consumer protection case: Oregon Attorney General filed a lawsuit against six major drug companies and pharmacy benefit managers for allegedly coordinating to inflate insulin prices, seeking $900 million in damages under the Unlawful Trade Practices Act.

Remedy

The lawsuit seeks an injunction to stop the alleged scheme, restitution for consumers, disgorgement of profits, and $900 million in damages.

InjunctionConsumer RefundsMonetary Penalty

Contract Impact

In-house legal teams should review vendor agreements between pharmaceutical manufacturers and pharmacy benefit managers (PBMs), as well as customer agreements with health plans, insurers, and pharmacies. Key clauses to examine include rebate calculation and payment terms, formulary inclusion/exclusion criteria, exclusivity or loyalty provisions, pricing transparency requirements, and audit rights. Changes may be needed to decouple rebates from list prices, ensure lower-cost insulin options are not excluded from formularies, enhance pricing disclosures, and include explicit compliance with antitrust laws to prevent coordinated price inflation.

Contract Search Terms

rebate agreementformulary placement clauselist price vs net priceexclusivity provisionsprice transparency requirementsaudit rights for rebatesanti-competitive coordinationtiered formulary structuremost favored nation clauseprice inflation prohibition

Laws Cited

Oregon Unlawful Trade Practices Act

Violation Types

Entity Details

Entity

Novo Nordisk, Sanofi, Eli Lilly, Express Scripts, CVS Caremark, Optum

Industry

Healthcare

Official Sources

Source Evidence

Entity Name
"three insulin manufacturers—Novo Nordisk, Sanofi, and Eli Lilly—and three pharmacy benefit managers—Express Scripts, CVS Caremark, and Optum."
Fine Amount
"seeking $900 million dollars in damages"
Laws Cited
"violations of Oregon’s Unlawful Trade Practices Act"
Violation Types
"worked together in a coordinated scheme to artificially inflate the price of insulin"

Related Enforcement Actions

OR

Paramount Skydance Corporation

Oregon Attorney General Dan Rayfield secured a temporary restraining order blocking Paramount Skydance Corporation's proposed $110 billion acquisition of Warner Bros. Discovery. The lawsuit, joined by 11 other state attorneys general, alleges the merger would harm Oregonians through higher prices, lower content quality, and reduced competition in film and television distribution.

OR

Glenmark Pharmaceuticals

$29.6M

Oregon Attorney General Dan Rayfield and a bipartisan coalition of states reached a $29.6 million settlement with Glenmark, a generic drug manufacturer accused of conspiring with other pharmaceutical companies to inflate prices and limit competition for numerous generic prescription drugs. The settlement requires Glenmark to cooperate in ongoing multistate litigations and implement internal reforms to ensure fair competition and antitrust compliance.

OR

Paramount Skydance Corporation

Oregon Attorney General Rayfield and a coalition of 11 other attorneys general filed a motion for a temporary restraining order and preliminary injunction to block the $110 billion acquisition of Warner Bros. Discovery, Inc. by Paramount Skydance Corporation. The lawsuit alleges the merger violates Section 7 of the Clayton Act by substantially lessening competition in theatrical film distribution and basic cable television licensing, which would lead to higher prices and reduced content quality for consumers.

OR

23andMe

$18.0M

A coalition of 42 state attorneys general settled bankruptcy claims against 23andMe following a 2023 data breach that compromised genetic data of 6.9 million customers. The settlement includes $150 million in allowed claims, with $18 million paid from bankruptcy funds, and requires enhanced data security measures for the successor entity, 23andMe Research Institute.

OR

Paramount Skydance Corporation

Oregon Attorney General Dan Rayfield and a coalition of 12 state attorneys general filed a lawsuit challenging the $110 billion acquisition of Warner Bros. Discovery by Paramount Skydance Corporation. The lawsuit alleges the merger violates Section 7 of the Clayton Act by substantially lessening competition in theatrical film distribution and basic cable television licensing, which could lead to higher prices and reduced choice for consumers.

OR

No privacy enforcement target identified

The provided press release is a media release from the Oregon Department of Justice announcing a multistate press conference of attorneys general from Oregon, California, Washington, Nevada, and New York advocating for increased state resources to address antitrust enforcement gaps following reduced federal oversight. No privacy-related enforcement actions, violations, penalties, or remedies are described in the document.